Retinal detachment with macular hole following intravitreal bevacizumab in patient with severe proliferative diabetic retinopathy.
Mitamura
Yoshinori
Y
Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. ymita@faculty.chiba-u.jp
Ogata
Kazuha
K
Oshitari
Toshiyuki
T
Asaumi
Noriko
N
Yamamoto
Shuichi
S
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003930:Diabetic Retinopathy / Q000150:complications / Q000188:drug therapy*; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D012163:Retinal Detachment / Q000139:chemically induced*; D012167:Retinal Perforations / Q000139:chemically induced
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab